Brain NMDA Receptors in Schizophrenia and Depression
Brain NMDA Receptors in Schizophrenia and Depression
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
N-methyl-D-aspartate (NMDA) receptor antagonists such as phencyclidine (PCP), dizocilpine (MK-801) and ketamine have long been considered a model of schizophrenia, both in animals and humans. However, ketamine has been recently approved for treatment-resistant depression, although with severe restrictions. Interestingly, the dosage in both conditio...
Alternative Titles
Full title
Brain NMDA Receptors in Schizophrenia and Depression
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_470bf0fbec4246bc84d295bf0d4a2642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_470bf0fbec4246bc84d295bf0d4a2642
Other Identifiers
ISSN
2218-273X
E-ISSN
2218-273X
DOI
10.3390/biom10060947
